2020-06-16, 20:17
DARPA taps Wyss technology to ID drugs for COVID-19 treatment
With a $16 million agreement from DARPA, Harvard’s Wyss Institute will use its technology to identify and test already FDA-approved drugs that may prevent or treat COVID-19 infection.
https://news.harvard.edu/gazette/story/2...edium=Feed&utm_source=Syndication
With a $16 million agreement from DARPA, Harvard’s Wyss Institute will use its technology to identify and test already FDA-approved drugs that may prevent or treat COVID-19 infection.
https://news.harvard.edu/gazette/story/2...edium=Feed&utm_source=Syndication